NEUROENDOCRINE DISORDERS IN PRADER-WILLI SYNDROME: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE
Open Access
- 15 June 2026
- journal article
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 83 (2) , 71-76
Abstract
Prader-Willi syndrome (PWS) is a rare genetic disease belonging to adjacent genes syndromes, caused by abnormal DNA methylation in the Prader-Willi critical region (PWCR) in 15q11.2-q13 region. Three main mechanisms are distinguished in its pathogenesis: genetic, molecular and physiological. The endocrine profile of PWS patients is characterized by polyglandular endocrinopathy: somatotropic insufficiency (90% of cases); hypogonadotropic hypogonadism with a possible combination with primary gonad lesions; central hypothyroidism. Special attention should be paid to latent adrenal insufficiency, which causes sudden death in stressful situations. The article presents a review of the current literature on the overall prevalence, mortality, pathogenesis, neuroendocrine disorders, modern diagnostic and therapeutic options. A systematic search of literature sources was carried out in the databases Scopus, PubMed, Web of Science, Embase, the Cochrane Library, MedLine.Keywords
This publication has 36 references indexed in Scilit:
- Growth hormone treatment in adults with Prader-Willi syndrome: an updateExpert Review of Endocrinology & Metabolism, 2025
- New drug approved for hyperphagia in Prader–Willi syndromeThe Lancet Diabetes & Endocrinology, 2025
- Relationship of thyroid function with genetic subtypes and treatment with growth hormone in Prader–Willi syndromeAmerican Journal of Medical Genetics Part A, 2024
- Acquiring Social Safety Engages Oxytocin Neurons in the Supraoptic Nucleus: Role of Magel2 DeficiencyNeuroendocrinology, 2024
- Thyroid function in children with Prader-Willi syndrome in Southern China: a single-center retrospective case seriesBMC Pediatrics, 2022
- SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndromeGenetics in Medicine, 2021
- Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunctionThe Lancet Diabetes & Endocrinology, 2021
- Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysisBMJ Paediatrics Open, 2020
- Neuroendocrine Regulation of Growth Hormone SecretionComprehensive Physiology, 2016
- Endocrine and metabolic aspects of adult Prader–Willi syndrome with special emphasis on the effect of growth hormone treatmentGrowth Hormone & IGF Research, 2004